Communication of pseudonymized patient data in the pharmaceutical laboratory providing medication

The hospital could communicate pseudonymized data relating to the health of patients treated with medicines for compassionate use in the pharmaceutical laboratory that facilitates the drug for clinical research purposes (Article 9.2.j) GDPR and paragraph 2.d) of DA 17a LOPDGDD) on the basis of the legitimate interest pursued by the laboratory.